We and others have during recent years shown that SOX11 is a diagnostic [13], prognostic [18,41,42], and functional biomarker in classical MCL [17], indolent MCL [43,44], ovarian cancer [15] and astrocytic gliomas [45]. Here, SOX11 is linked to ovarian cancer.